Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 15, 2011, and December 20, 2011. The filing details a public equity offering and a material amendment to the company's senior secured credit facility.
Key Financial Metrics and Capital Structure
- Equity Offering: Sold 8,333,333 shares of common stock at $7.50 per share.
- Over-Allotment: Underwriters exercised their option to purchase an additional 1,249,999 shares on December 16, 2011.
- Net Proceeds: Approximately $67.6 million received after deducting underwriting discounts, commissions, and estimated expenses.
- Debt Instrument: 12.875% Senior Notes due 2018.
- Liquidity Impact: Proceeds are designated to fund acquisition strategy, general corporate purposes, and potential debt repayment.
Material Changes and Agreements
Underwriting Agreement: Entered into on December 15, 2011, with Jefferies & Company, Inc. and Citigroup Global Markets Inc. as representatives. The transaction closed on December 20, 2011.
Credit Facility Amendment: A Third Amendment to the Senior Secured Credit Facility was executed on December 15, 2011, conditioned on receiving at least $59.3 million in net cash proceeds. Key changes include:
- Ownership Limits: Allows a single affiliate to hold up to 5% of Senior Notes and all affiliates to hold up to 15%.
- Debt Prepayment: Permits the use of up to $59.3 million of offering proceeds to prepay Senior Notes within 120 days.
- Acquisition Financing: Indebtedness for permitted acquisitions financed by excluded equity issuances will not count toward the $25 million annual debt incurrence cap.
- Leverage Ratio Adjustments: The maximum consolidated leverage ratio was amended to the following schedule:
| Fiscal Quarter Ending | Maximum Consolidated Leverage Ratio |
|---|---|
| June 30, 2011 | 4.25:1.0 |
| September 30, 2011 | 6.25:1.0 |
| December 31, 2011 | 6.00:1.0 |
| March 31, 2012 through September 30, 2012 | 5.75:1.0 |
| December 31, 2012 through September 30, 2013 | 5.25:1.0 |
| December 31, 2013 through September 30, 2014 | 4.75:1.0 |
| December 31, 2014 and thereafter | 4.00:1.0 |
Outlook and Management Commentary
Management intends to use the net proceeds principally to fund its acquisition strategy. The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period, as this is a transactional filing rather than a periodic financial report.
Investor Verification Checklist
- Verify the final closing date and total share count including the full exercise of the over-allotment option.
- Confirm the actual amount of Senior Notes prepaid using the offering proceeds within the 120-day window.
- Review the specific terms of the "Permitted Acquisition" definition to understand the scope of the debt incurrence cap exemption.
- Monitor the company's consolidated leverage ratio against the new amended schedule to ensure compliance.
- Check subsequent filings for the actual use of proceeds regarding acquisitions versus debt repayment.